and the D4Z4 region, leading to an inappropriate activation of FRG1, FRG2 and ANT1, which are proximal to the 4q35 region. Indeed, transgenic mice overexpressing FRG1 in skeletal muscle develop a muscular dystrophy [9] . However, patient with FSHD show a very limited, if any, overexpression of FRG1 as compared to healthy individuals [10, 11] .
Another interesting feature of the D4Z4 repeated element is the presence of an open reading frame (ORF) containing a double homeobox sequence, DUX4 [12] , which is preceded by a putative promoter element that displays high transcriptional activity in transient expression studies. Some of us contributed to the demonstration that DUX4 is transcribed both in cells transfected with D4Z4 elements and endogenously in FSHD myoblasts [13, 14] . These data are suggestive for a pathogenic transcriptional role of the D4Z4 element in FSHD [12, 15] .
Moreover, some of us have shown that the D4Z4 array contains a strong transcriptional activator which may up-regulate transcription of neighboring genes [16] . We have also demonstrated that a nuclear matrix attachment site (S/MAR) is located in the vicinity of the D4Z4 repeat and separates it from the transcriptional enhancer [17] . [16] .
This S/MAR is prominent in normal human myoblasts and non-muscular human cells, and much weaker in muscle cells derived from patients with FSHD, suggesting that the D4Z4 repeat array and upstream genes are located in two distinct loops in nonmuscular cells and healthy human myoblasts, whereas it is in a single loop in FSHD myoblasts. This S/MAR may also function as an insulator, thus blocking the D4Z4 enhancer in normal, but not in FSHD cells
Contraction of the D4Z4 repeat alone is not sufficient to cause the disease. Indeed, similar repeat arrays are present also on chromosome 10 and on two equally common alleles of chromosome 4, but only contractions associated with the 4qA allele variant are associated with the disease [10] . Another polymorphic region proximal to D4Z4 [18] directly coincides with the S/MAR we previously described, suggesting that changes in the chromatin organization of the region may play a key role in the disease [16, 17] .
Little is known also about the molecular mechanisms that induce the progressive muscle degeneration observed in FSHD, and many groups have observed apparently contradictory gene expression patterns, particularly in the 4q35 region, by using different types of cells from healthy individuals and patients with FSHD [19] .
Moreover, in patients affected with FSHD, it is quite common to observe the co-existence of affected and apparently healthy muscles. In previous studies, myoblasts, which were obtained from muscle typically affected in FSHD, manifested an increased susceptibility to oxidative stress during proliferation [20] . On the contrary, in another study, cells expanded from unaffected FSHD muscles showed no morphological abnormalities and were proposed as a suitable tool for clinical trials of autologous cell transplantation [21] . The apparent discrepancy between these two studies may be explained by differences between the sources of myoblasts: from clinically affected muscles in the first study and from unaffected muscles in the second study. 
Materials and methods

Patients
We used fresh and frozen muscles obtained from 14 male and female patients with genetically confirmed diagnosis of FSHD (20- [23, 24] (Table 1) .
To assess whether the biopsied muscle was affected and to evaluate the severity of its involvement, we used clinical and histopathologic criteria. [25] .
Myoblast isolation
Myoblasts purification
Harvested cells were then purified with an immuno-magnetic sorting system (Miltenyi Biotec, Paris, France) using an anti-CD56/NCAM antibody [25] . Purified 
Immunocytochemistry
Cell staining was performed as previously described [25] 
Optimization of myoblast purification
At the beginning of this study we used three different methods to isolate satellite cells: 'non-adherent explants' in collagen-coated Petri dishes, 'adherent-explants' in collagen-coated Petri dishes and explants grown in Matrigel. Migrating cells harvested in these three different conditions, were then counted and tested for myogenicity.
The number of cells that migrated from the explants was higher for the explants grown in Matrigel (Fig. 1A) . Migrating cells were then analyzed for their myogenicity by immunofluorescence staining for desmin, a marker of muscle precursor cells [27] . Myogenicity of the culture was calculated by dividing the number of desmin-positive cells by the total number of cells (DAPI-stained nuclei) in a given microscopic field. As shown in (Fig. 1B) (Fig. 1C, right panel) . We did not detect any morphological differences in FSHD myoblasts from clinically affected and unaffected FSHD muscles and control muscles by phase contrast microscopy ( Fig. 2A) . We did not observe necrotic cells in any of the FSHD cultures in agreement with recently published data [29] . As myoblast structure directly influences the organization of the resulting myotube, we decided to stain myoblasts with phalloidin to analyze the arrangement of the actin microfilaments. Normal stress fibres were observed in both control and FSHD myoblast cell cultures (Fig. 2B) .
Myoblasts derived from patients with FSHD and controls have similar proliferation rates and gene expression patterns
We then examined by immuno-fluorescence the expression and localization patterns of MyoD, a myoblast lineage-specific marker, and Ki67, a cell-proliferation marker. In growth conditions, both MyoD and Ki67 were localized in the nuclear compartment and similarly expressed in FSHD and control primary myoblasts (Fig. 3) . 
Fig. 2 Comparative morphological analysis of control and FSHD myoblasts. (A) Phase contrast images of a representative control (a; CTL 6) and FSHD (b; FSHD13) myoblast culture showing that FSHD myoblasts have a normal morphology, 10ϫ magnification. (B) Observation of actin microfilaments using phalloidin (red) and DAPI (blue) immunostaining on a representative control (a; CTL1) and a representative FSHD (b; FSHD3) myoblast cultures show normal cytoskeleton morphology, 20ϫ magnification, bar ϭ 10 m. All these observations were done on the 14 CTL and FSHD myoblast cultures.
Fig. 3 Characterization of FSHD and control cells proliferation. Representative images of a CTL (a, b, e, f; CTL1) and FSHD (c, d, g, h; FSHD13) showing co-immunofluorescence with anti-Ki67 (a, c; red) and anti-desmin (b,d; green), anti-MyoD (e, g; red) and anti-desmin (f, h; green) antibodies and DAPI nuclear staining (blue). MyoD and Ki67 are localized into the nucleus 20ϫ magnification, bar ϭ 10 m. Experiments were performed on two controls and three FSHD cultures.
In conclusion, we did not detect differences in either the proliferation or the expression of MyoD in FSHD myoblasts.
FSHD myoblasts from affected and unaffected muscles are both susceptible to an induced oxidative stress
As a previous study demonstrated that myoblasts from affected FSHD muscles exhibit increased susceptibility to oxidative stress [20] (Fig. 4A and B) . (Fig. 5B) . (Fig. 6) . (Fig. 7A) , FSHD myoblasts appeared either thinner (Fig. 7B) or  deformed (Fig. 7C) with randomly localized nuclei. Eight of the 14  FSHD cell cultures (i.e., FSHD 1, 4, 3, 2, 7, 5, 6, 9 ) had a significant increase in the proportion of myotubes containing 3 to 10 nuclei each compared to controls (Fig. 8A) , but no myotubes with more than 50 nuclei were detected in these FSHD cell cultures. Moreover, in these cultures a large proportion of myotubes had a cell diameter Ͻ20 m (Fig. 8B) . In these cell cultures we did not find very large myotubes (Ͼ100 m), which were observed in the other FSHD and control cell cultures. These data suggest that, in the FSHD 1, 4, 3, 2, 7, 5, 6 and 9 cultures, a large proportion of myotubes are atrophic. In addition, we observed a significant inverse correlation (r ϭ Ϫ0.77; P Ͻ 0.02) between MFI and the proportion of atrophied myotubes in FSHD culture (Fig. 8C) .
This result indicates that all FSHD myoblasts, independently from the clinical status of the muscle they were derived from, are more susceptible to an induced oxidative stress than control cells.
Differentiating FSHD myoblasts from affected and unaffected muscles have an abnormal morphology
Next we wanted to check whether myoblasts from clinically affected and unaffected FSHD muscles could differentiate normally into myotubes. We then induced myoblast differentiation by shifting to differentiating medium (2% foetal calf serum). The expression and localization of p21 and of one-muscle differentiation markers (myogenin) were similar in FSHD and control cells (Fig. 5A). In addition, we examined the maturation degree of these myotubes by following the immuno-localization of the MF20 antibody (which recognizes all myosins) and an anti-␣-actinin antibody, which stains Z lines and is used to check the sarcomeric organization
We did not detect defects in the maturation and sarcomeric organization of the myotubes derived from both affected and unaffected FSHD muscles. To assess fusion competence, we calculated the MFI, which is the ratio between the nuclei present in myotubes versus the total number of nuclei in a given field, where a myotube is defined as a muscle cell containing at least three or more nuclei. We obtained MFI values between 37% and 70% in most of the control and FSHD cell cultures, except for FSHD1 and FSHD14. In FSHD1, the fusion index was much lower (18%) and in FSHD14 the fusion index was higher (85%) than in the other cell cultures
Although the biochemical features we analyzed were similar in both FSHD and control cells, we observed an abnormal morphology in all FSHD myoblasts undergoing differentiation. Whereas control myoblasts fuse to form branched myotubes with aligned nuclei
In Yip and Picketts (2003) [30] . The DMI determined the proportion of myotubes in the culture with abnormal phenotype. This proportion ranged from 13% to 40% whereas the DMI is null in controls (Fig. 9) . We found a positive relationship between the MFI and the proportion of deformed myotubes. Indeed, the average MFI of FSHD cell cultures which have deformed myotubes was of 57% while those presenting no deformation were of 38%. These data might suggest that the more the FSHD myoblasts are able to fuse, the more they tend to form deformed myotubes. These defects were not correlated with the overall disease severity and the degree of histo-pathological abnormalities of the muscle of origin.
When myoblasts fuse into myotubes, the organization of the cytoskeleton changes dramatically [31] . To address this question, we analyzed the actin cytoskeleton and the microtubules organization using, respectively, phalloidin staining and ␣ and ␤ tubulin immuno-localization in both control and FSHD myotubes (Fig. 10) . In controls, actin and microtubules are organized into a filamentous network running parallel to the long axis of the syncitium. A similar pattern is observed in FSHD myotubes, which belong to the 'atrophied' group of FSHD cell cultures. In contrast, in FSHD cultures, which present a high proportion of deformed myotubes, microtubules and actin networks were highly disorganized. These data confirm that FSHD myoblasts present morphological differentiation defects.
Discussion
The pathogenetic mechanism of facioscapulohumeral muscular dystrophy remains largely unknown, despite 14 years of intense studies after the discovery of the genetic defect, a partial reduction of the D4Z4 repeat array on chromosome 4 [1, 2] . Recent attempts to understand this disorder have focused on identifying cellular pathways involved in FSHD and on unravelling the genetic and epigenetic mechanisms of the disease [10, 11, 32] [33] [34] [35] and DMD [36] . However, our results in primary muscle cells are similar to those reported by Yip and Picketts [30] [11, 20] as well as morphological alterations, such as irregular cytoplasmic shape and a 'vacuolar/necrotic' phenotype in cultured FSHD myoblasts [20] . Recently, Vilquin et al. [21] [29] . We, [14] .
Fig. 4 Comparative analysis of control and FSHD myoblasts response to H202-induced oxidative stress. (A) A representative flow cytometry analysis on myoblasts from one control (CTL1), one clinically affected FSHD (FSHD13) and one clinically unaffected FSHD (FSHD12). FACS experiments were conducted on FSHD and control myoblasts after 24 hrs exposure to increasing doses of H2O2. Live cells stained with calcein (green) were sorted with the FL1 channel (down-right window) and dead cells stained with ethidium homodimer-1 (red) were sorted with the FL2 channel (up-left window). (B) Flow cytometry analysis of myoblasts from all control (blue), unaffected FSHD (yellow) and affected FSHD (red). Experiments were performed twice on two independent cultures.
Therefore, these abnormalities could be responsible for the muscle weakness observed in patients with FSHD and provide an important marker for FSHD myoblasts.
